CIK 0001846253
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
OmniAb, Inc.
Sign in to watch- Ticker
- OABI
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 510-250-7800
- Business address
- 5980 HORTON STREET, SUITE 600, EMERYVILLE, CA, 94608
- Former names
- Avista Public Acquisition Corp. II
Securities
- OABI Common Stock Nasdaq
- OABIW Warrant Nasdaq
- 4 Open-market buy President and CEO bought 225,000 shares at $5.19 ($1,167,750)
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Executive Officer gave up 18,919 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 7,609 shares (to pay taxes)
- 4 Exercise or conversion Director acquired 13,173 shares (option exercise)
- 4 Shares withheld for taxes Chief Executive Officer gave up 13,221 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 7,195 shares (to pay taxes)
- 4 Open-market buy Chief Executive Officer bought 200,000 shares at $5.05 ($1,010,000)
- 4/A Derivatives Options or other derivatives
- 4 Shares withheld for taxes Executive VP, Finance & CFO gave up 16,081 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 9,184 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 5,403 shares (to pay taxes)
- 4 Exercise or conversion Director acquired 17,770 shares (option exercise)
- 4 Open-market buy President and CEO bought 95,000 shares at $4.27 ($405,517)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Director acquired 17,770 shares (option exercise)
- 4 Open-market buy President and CEO bought 45,000 shares at $5.48 ($246,600)
- 4 Exercise or conversion Director acquired 1,896 shares (option exercise)
- 4 Derivatives Options or other derivatives
Page 5 of 9 · 174 filings